Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP)

A critical need exists to develop diverse biomedical strategies for the widespread use of HIV Pre-Exposure Prophylaxis (HIV PrEP). This manuscript describes a subcutaneous reservoir-style implant for long-acting delivery of tenofovir alafenamide (TAF) for HIV PrEP. We detail key parameters of the TA...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmaceutics
Auteurs principaux: Li, Linying, Johnson, Leah M., Krovi, Sai Archana, Demkovich, Zach R., van der Straten, Ariane
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694512/
https://ncbi.nlm.nih.gov/pubmed/33167509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111057
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires